相似文献
1
Timing is everything for compassionate use of delamanid.
Nat Med. 2015 Mar;21(3):211. doi: 10.1038/nm.3823.
2
Notes from the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis - United States, 2017.
MMWR Morb Mortal Wkly Rep. 2018 Sep 7;67(35):996-997. doi: 10.15585/mmwr.mm6735a6.
3
Access sought to tuberculosis drug from nutraceutical company.
Nat Med. 2015 Feb;21(2):103. doi: 10.1038/nm.3805. Epub 2015 Feb 2.
4
Delamanid for Extensively Drug-Resistant Tuberculosis.
N Engl J Med. 2015 Jul 16;373(3):291-2. doi: 10.1056/NEJMc1415332.
5
First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline.
Eur Respir J. 2016 Sep;48(3):935-8. doi: 10.1183/13993003.00637-2016. Epub 2016 Jun 10.
6
Bedaquiline plus delamanid for XDR tuberculosis.
Lancet Infect Dis. 2016 Mar;16(3):294. doi: 10.1016/S1473-3099(16)00047-5.
7
Compassionate and optimum use of new tuberculosis drugs.
Lancet Infect Dis. 2015 Oct;15(10):1131-1132. doi: 10.1016/S1473-3099(15)00296-0. Epub 2015 Sep 20.
8
Compassionate and optimum use of new tuberculosis drugs.
Lancet Infect Dis. 2015 Oct;15(10):1131. doi: 10.1016/S1473-3099(15)00294-7. Epub 2015 Sep 20.
9
Emergence of Low-level Delamanid and Bedaquiline Resistance During Extremely Drug-resistant Tuberculosis Treatment.
Clin Infect Dis. 2019 Sep 13;69(7):1229-1231. doi: 10.1093/cid/ciz074.
10
Final treatment outcomes of multidrug- and extensively drug-resistant tuberculosis patients in Latvia receiving delamanid-containing regimens.
Eur Respir J. 2017 Nov 9;50(5). doi: 10.1183/13993003.01105-2017. Print 2017 Nov.
引用本文的文献
1
Anti-Tubercular Properties of 4-Amino-5-(4-Fluoro-3- Phenoxyphenyl)-4-1,2,4-Triazole-3-Thiol and Its Schiff Bases: Computational Input and Molecular Dynamics.
Antibiotics (Basel). 2020 Aug 31;9(9):559. doi: 10.3390/antibiotics9090559.
2
In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against .
Drug Des Devel Ther. 2020 Mar 9;14:1027-1039. doi: 10.2147/DDDT.S228381. eCollection 2020.
3
Anti-Tubercular Activity of Substituted 7-Methyl and 7-Formylindolizines and In Silico Study for Prospective Molecular Target Identification.
Antibiotics (Basel). 2019 Dec 3;8(4):247. doi: 10.3390/antibiotics8040247.
4
Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues.
PLoS One. 2019 Jun 4;14(6):e0217270. doi: 10.1371/journal.pone.0217270. eCollection 2019.
5
Current strategies to treat tuberculosis.
F1000Res. 2016 Oct 26;5. doi: 10.12688/f1000research.7403.1. eCollection 2016.
6
Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis.
Sci Rep. 2016 Jul 13;6:29717. doi: 10.1038/srep29717.
7
Next-generation antimicrobials: from chemical biology to first-in-class drugs.
Arch Pharm Res. 2015 Sep;38(9):1702-17. doi: 10.1007/s12272-015-0645-0. Epub 2015 Aug 11.
本文引用的文献
1
Access sought to tuberculosis drug from nutraceutical company.
Nat Med. 2015 Feb;21(2):103. doi: 10.1038/nm.3805. Epub 2015 Feb 2.
2
Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort.
Clin Infect Dis. 2015 Jan 15;60(2):188-94. doi: 10.1093/cid/ciu786. Epub 2014 Oct 15.
3
ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use.
Eur Respir J. 2014 Sep;44(3):811-5. doi: 10.1183/09031936.00060414. Epub 2014 May 15.
4
Delamanid for multidrug-resistant pulmonary tuberculosis.
N Engl J Med. 2012 Jun 7;366(23):2151-60. doi: 10.1056/NEJMoa1112433.
5
Sterilizing activity of novel TMC207- and PA-824-containing regimens in a murine model of tuberculosis.
Antimicrob Agents Chemother. 2011 Dec;55(12):5485-92. doi: 10.1128/AAC.05293-11. Epub 2011 Sep 19.
Zotero 插件